Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Switzerland Alphadex First Trust | FSZ | Jan 30, 2025 | 66.89 | +0.62 |
Switzerland Index MSCI Ishares | EWL | Jan 30, 2025 | 50.02 | +0.87 |
SWK Holdings | SWKH | Jan 30, 2025 | 16.48 | -1.02 |
Swvl Holdings A | SWVL | Jan 30, 2025 | 5.23 | +5.87 |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | Jan 30, 2025 | 1.70 | -0.88 |
Sylvamo | SLVM | Jan 30, 2025 | 81.20 | +1.15 |
Symbotic | SYM | Jan 30, 2025 | 29.82 | +1.91 |
Synaptics | SYNA | Jan 30, 2025 | 86.16 | -1.95 |
Synaptogenix | SNPX | Jan 30, 2025 | 3.35 | -6.23 |
Synchronoss Technologies | SNCR | Jan 30, 2025 | 9.98 | +3.74 |
Synchrony Financial | SYF | Jan 30, 2025 | 69.47 | +1.02 |
Synchrony Financial Pref A | SYF-B | Jan 30, 2025 | 26.04 | +0.26 |
Synchrony Financial Pref A | SYF-A | Jan 30, 2025 | 19.52 | +0.19 |
Syndax Pharmaceuticals | SNDX | Jan 30, 2025 | 14.21 | -0.21 |
Synergetics Inc | FTGC | Jan 30, 2025 | 24.91 | +0.28 |
Synergy CHC | SNYR | Jan 30, 2025 | 4.20 | 0.00 |
Synlogic | SYBX | Jan 30, 2025 | 1.40 | -2.45 |
Synopsys | SNPS | Jan 30, 2025 | 526.36 | +2.66 |
Synovus Financial | SNV | Jan 30, 2025 | 56.51 | +1.75 |
Synovus Financial D Pref | SNV-D | Jan 30, 2025 | 25.27 | +0.16 |
Synovus Financial E Pref | SNV-E | Jan 30, 2025 | 25.85 | +0.12 |
Syntec Optics | OPTX | Jan 30, 2025 | 2.25 | +5.14 |
Sypris Solutions | SYPR | Jan 30, 2025 | 2.19 | +8.08 |
Syra Health | SYRA | Jan 30, 2025 | 0.50 | -8.22 |
Syros Pharmaceuticals | SYRS | Jan 30, 2025 | 0.17 | -11.05 |
Sysco | SYY | Jan 30, 2025 | 73.34 | +1.97 |
System1 A | SST | Jan 30, 2025 | 0.68 | -0.61 |
T Stamp A | IDAI | Jan 30, 2025 | 3.70 | -5.13 |
T-Mobile US | TMUS | Jan 30, 2025 | 234.37 | -0.33 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Jan 30, 2025 | 43.43 | +0.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.